Documents
201 documents
Sort by:
Subscribe to the latest documents
- Date
- Relevance
-
List of patient-friendly terms for the package leaflet
In order to optimise the readability of the package leaflet, the MEB has revised the list of patient-friendly terms. The list has ...
-
Poster Renske ten Ham: Challenges in development and market authorisation of ATMP in Europe
-
Poster Tahira Nakchedi: Regulatory experience with non-clinical studies of cell-based therapy
-
Assessment report novel food status L-fucose
-
MEB 21: Statement of ‘abbreviated indications’ on OTC medicinal product packaging
Directive 2001/83/EC discusses European regulations on labelling. In accordance with Article 54(n), the outer packaging of ...
-
Declaration on modification of information in the printed SmPC and package leaflet pertaining to patented indications
-
Letter to stakeholders regarding the implementation of safety features under the Falsified Medicines Directive 2011/62/EU
The delegated Regulation on the characteristics of the safety features and the new medicine verification system will apply as of ...
-
MEB 8: Guideline on the excipients in the label and the package leaflet of medicinal products for human use
-
Declaration by the applicant pertaining to the application for a Duplex marketing authorisation (Model I)
-
The MEB: Good medicines used better (short version)